US Patent Issued to The Board of Regents of The University of Texas System, Children's Hospital Medical Center on April 7 for "Use of 6-thio-dG to treat therapy-resistant telomerasepositive pediatric brain tumors" (Texas, Ohio Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,293, issued on April 7, was assigned to The Board of Regents of The University of Texas System (Austin, Texas) and Children's Hospital Medical Center (Cincinnati).

"Use of 6-thio-dG to treat therapy-resistant telomerasepositive pediatric brain tumors" was invented by Jerry Shay (Dallas) and Rachid Drissi (Cincinnati).

According to the abstract* released by the U.S. Patent & Trademark Office: "Brain tumors remain the leading cause of cancer-related deaths in children and often are associated with long-term sequelae among survivors of current therapies. Telomerase and telomeres play important roles in cancer, representing attractive therapeutic targets to treat children with poor-p...